Skip to main content

North America to Dominate the Multiplex Assays Market for Research & Development and Disease & Disorder Applications

The applications segment of the multiplex assays market is categorized into research & development, diseases & disorders, companion diagnostics, and other applications. The research & development segment is expected to account for the largest share of the multiplex assays market in 2016. Factors such as convenience in performing the assays and faster results offered by multiplex assays are driving the growth of this segment.

North America is expected to account for the largest share of the multiplex assays market in 2016. This region is estimated to account for 44.7% of the total market. Europe is the second-largest source, this regional market is driven by the availability of government funds.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=61593314

The adoption of companion diagnostics for increasing safety & efficacy of therapies, need for effective analytical platforms in research to reduce operational costs, advantages of multiplexing over traditional assays are the major drivers for the multiplex assays market. Increasing validation of biomarkers in molecular and protein diagnostics are expected to further drive the growth of the multiplex assays market.

Major players in the multiplex assays market include Luminex Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Illumina, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and QIAGEN N.V. (Netherlands).

The end user segment of the multiplex assays market is segmented into academic and research institutes, hospitals, clinical laboratories, pharmaceutical and biotechnology companies, and other end users. The pharmaceutical and biotechnology companies segment is estimated to account for the largest share in 2016.

To Know More Download Sample Report Pages: http://www.marketsandmarkets.com/requestsample.asp?id=61593314

Article Credit: Healthcare DC(https://healthcaredc.wordpress.com)

Comments

Popular posts from this blog

Dental Bone Graft Substitutes Market worth $664.3 Million by 2021

According to a new market research report  " Dental Bone Graft Substitutes Market by Type (Synthetic Bone Grafts, Xenografts, Allografts, and Demineralized Allografts), by Application (Sinus Lift, Ridge Augmentation, Socket Preservation, Periodontal Defect Regeneration, and Implant Bone Regeneration), by Product (Biooss, Osteograf, Grafton, and Others) - Forecast to 2021" , published by MarketsandMarkets, The global market is expected to reach USD 664.3 Million by 2021, at a CAGR of 9.8% from 2016 to 2021. Factors such as technological advancements in the field of dental bone grafts and increase in the number of bone grafting procedures are expected to drive the growth of the global dental bone grafts substitutes market. Several insurance providers in the U.S. and various countries in the European region have assisted the medical sector to introduce and encourage the usage of latest synthetic bone grafts and demineralized allografts. This report mainly considers four type

Ostomy Care Accessories Market

The global ostomy care accessories market is projected to reach USD 2.99 billion by 2022 from USD 2.40 billion in 2017, at the CAGR of 4.5%. The high incidence of bladder/colorectal cancer/inflammatory bowel disease; rising geriatric population; growing number of awareness programs to educate patients regarding the use of ostomy products; technological advancements in ostomy products; and efficient reimbursement system in developed countries are some of the factors driving the growth of this market. The ostomy care accessories market is expected to grow at the highest CAGR during the forecast period owing to the growing skin problems due to frequent removal and re-application of skin barrier of ostomy bags and rising awareness about care of peristomal skin. Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=267183143 By system, the ostomy bags market is segmented into one-piece, two-piece, and skin barrier. Two-piece bags are expected to hold the

Cartilage Regeneration Market | Growth and Analysis, Industry Trends, Size, Shares, Forecast

The global  cartilage regeneration market  is projected to reach USD 779.8 Million by 2021 from USD 414.6 Million in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021. Increase in obese population and rising incidence of sports injuries are the major factors driving the growth of cartilage regeneration market. However, high cost of therapy and unfavorable reimbursement scenario are the major factors that are restraining the growth of the market. The cartilage regeneration market is segmented on the basis of treatment modalities, application, and region. Based on treatment modalities, the market is segmented into cell based approaches and non-cell based approaches. Cell based approaches are further segmented into chondrocyte transplantation, growth factor technology, and stem cells. Non-cell based approaches are segmented into tissue scaffolds and cell-free composites. The cell based approaches segment is expected to account for the largest market share i